What does Apotheek Vanderheyden Neeroeteren do?

Apotheek Vanderheyden Neeroeteren is a pharmacy in Maaseik. Public Limited, started on 20 March 1998, 1 establishment.

What is the address of Apotheek Vanderheyden Neeroeteren?

The registered office of Apotheek Vanderheyden Neeroeteren is located at Spilstraat 42, 3680 Maaseik.

Is Apotheek Vanderheyden Neeroeteren still active?

Yes. According to the CBE (30 October 2026) Apotheek Vanderheyden Neeroeteren is active, legal situation “Normale toestand”, started on 20 March 1998.

Is Apotheek Vanderheyden Neeroeteren registered on Peppol?

Yes, Apotheek Vanderheyden Neeroeteren is registered on the Peppol network with ID 0208:0462921909.

What is the enterprise number of Apotheek Vanderheyden Neeroeteren?

The enterprise number of Apotheek Vanderheyden Neeroeteren is BE0462921909.

When was Apotheek Vanderheyden Neeroeteren founded?

Apotheek Vanderheyden Neeroeteren was founded on 20 March 1998.

Who are the directors of Apotheek Vanderheyden Neeroeteren?

According to the 2026 annual accounts, the directors of Apotheek Vanderheyden Neeroeteren are: VANDERHEYDEN FARMA BV.

Is Apotheek Vanderheyden Neeroeteren a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 March 1998; 5 annual accounts filed, latest fiscal year 2026; 1 directors known from the annual account.

How much profit did Apotheek Vanderheyden Neeroeteren make in 2026?

Apotheek Vanderheyden Neeroeteren recorded a loss after taxes of € 181,264 in financial year 2026.

What is the revenue of Apotheek Vanderheyden Neeroeteren?

As a small company, Apotheek Vanderheyden Neeroeteren is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 35,796.

How much does an employee at Apotheek Vanderheyden Neeroeteren earn?

The average wage cost per full-time employee at Apotheek Vanderheyden Neeroeteren was € 166,600 in 2026: staff costs of € 166,622 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Vanderheyden Neeroeteren have?

According to the 2026 annual accounts, Apotheek Vanderheyden Neeroeteren has 1 full-time equivalents (FTE).

Apotheek Vanderheyden Neeroeteren (Public Limited)

Dossier Apotheek Vanderheyden Neeroeteren, printed on 30 October 2026 from databakkes.be/en/0462921909/apotheek-vanderheyden-neeroeteren. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 18 % of short-term debt in 2026; threshold 65 %.

Financials

Financial year 2026

Apotheek Vanderheyden Neeroeteren from Maaseik, company number BE0462921909, closed financial year 2026 with a result of € -181,264 after tax. For that financial year Apotheek Vanderheyden Neeroeteren recorded a gross margin of € 35,796 and equity of € 172,665. Compared with financial year 2025, the result moved from € 101,617 to € -181,264. The company made a loss. The buffer shrank hard: equity is 51 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 15, 2026.

What it is worth Shrank hard

€ 172,665

▼ 51% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -181,264

▼ still € 101,617 profit in 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 3,261

▼ 99% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 110,665.

People and assets in 2026

Full-time equivalents

▼ 1.4 vs 2025

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 166,622

▲ 23% vs 2025

€ 166,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 834

▼ 47% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 62,132

▼ 36% vs 2025

€ 36,686 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 3,124

▼ 94% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 294,163 Gross margin 2023: € 294,163 First fiscal year in the series	€ 284,091 Gross margin 2024: € 284,091 ▼ 3% vs 2023 (€ 294,163) Unfavourable step	€ 290,916 Gross margin 2025: € 290,916 ▲ 2% vs 2024 (€ 284,091) Favourable step	€ 35,796 Gross margin 2026: € 35,796 ▼ 88% vs 2025 (€ 290,916) Unfavourable step	▼ 88%
Profit after taxes	€ 109,432 Profit after taxes 2023: € 109,432 First fiscal year in the series	€ 92,408 Profit after taxes 2024: € 92,408 ▼ 16% vs 2023 (€ 109,432) Unfavourable step	€ 101,617 Profit after taxes 2025: € 101,617 ▲ 10% vs 2024 (€ 92,408) Favourable step	€ -181,264 Profit after taxes 2026: € -181,264 ▼ € 282,881 vs 2025 (€ 101,617) Unfavourable step	▼ € 282,881
Equity	€ 349,904 Equity 2023: € 349,904 First fiscal year in the series	€ 352,312 Equity 2024: € 352,312 ▲ 1% vs 2023 (€ 349,904) Favourable step	€ 353,929 Equity 2025: € 353,929 Unchanged (€ 352,312) Favourable step	€ 172,665 Equity 2026: € 172,665 ▼ 51% vs 2025 (€ 353,929) Unfavourable step	▼ 51%
Total debts	€ 516,867 Total debts 2023: € 516,867 First fiscal year in the series	€ 433,656 Total debts 2024: € 433,656 ▼ 16% vs 2023 (€ 516,867) Favourable step	€ 456,532 Total debts 2025: € 456,532 ▲ 5% vs 2024 (€ 433,656) Unfavourable step	€ 82,464 Total debts 2026: € 82,464 ▼ 82% vs 2025 (€ 456,532) Favourable step	▼ 82%
Cash	€ 353,520 Cash 2023: € 353,520 First fiscal year in the series	€ 296,401 Cash 2024: € 296,401 ▼ 16% vs 2023 (€ 353,520) Unfavourable step	€ 413,781 Cash 2025: € 413,781 ▲ 40% vs 2024 (€ 296,401) Favourable step	€ 3,261 Cash 2026: € 3,261 ▼ 99% vs 2025 (€ 413,781) Unfavourable step	▼ 99%
Land & buildings	€ 188,100 Land & buildings 2023: € 188,100 First fiscal year in the series	€ 167,200 Land & buildings 2024: € 167,200 ▼ 11% vs 2023 (€ 188,100) Unchanged	€ 146,300 Land & buildings 2025: € 146,300 ▼ 12% vs 2024 (€ 167,200) Unchanged	€ 125,400 Land & buildings 2026: € 125,400 ▼ 14% vs 2025 (€ 146,300) Unchanged	▼ 14%
Retained profit	€ 287,904 Retained profit 2023: € 287,904 First fiscal year in the series	€ 290,312 Retained profit 2024: € 290,312 ▲ 1% vs 2023 (€ 287,904) Favourable step	€ 291,929 Retained profit 2025: € 291,929 ▲ 1% vs 2024 (€ 290,312) Favourable step	€ 110,665 Retained profit 2026: € 110,665 ▼ 62% vs 2025 (€ 291,929) Unfavourable step	▼ 62%
Dividend	€ 100,000 Dividend 2023: € 100,000 First fiscal year in the series	€ 90,000 Dividend 2024: € 90,000 ▼ 10% vs 2023 (€ 100,000) Unchanged	€ 100,000 Dividend 2025: € 100,000 ▲ 11% vs 2024 (€ 90,000) Unchanged	€ 0 Dividend 2026: € 0 ▼ 100% vs 2025 (€ 100,000) Unchanged	▼ 100%
Bank debt	€ 162,259 Bank debt 2023: € 162,259 First fiscal year in the series	€ 133,169 Bank debt 2024: € 133,169 ▼ 18% vs 2023 (€ 162,259) Favourable step	€ 97,110 Bank debt 2025: € 97,110 ▼ 27% vs 2024 (€ 133,169) Favourable step	€ 62,132 Bank debt 2026: € 62,132 ▼ 36% vs 2025 (€ 97,110) Favourable step	▼ 36%
Balance sheet total	€ 866,770 Balance sheet total 2023: € 866,770 First fiscal year in the series	€ 785,967 Balance sheet total 2024: € 785,967 ▼ 9% vs 2023 (€ 866,770) Unchanged	€ 810,461 Balance sheet total 2025: € 810,461 ▲ 3% vs 2024 (€ 785,967) Unchanged	€ 255,129 Balance sheet total 2026: € 255,129 ▼ 69% vs 2025 (€ 810,461) Unchanged	▼ 69%
Employees (FTE)	2.4 Employees (FTE) 2023: 2.4 First fiscal year in the series	2.4 Employees (FTE) 2024: 2.4 Unchanged (2.4) Unchanged	2.4 Employees (FTE) 2025: 2.4 Unchanged (2.4) Unchanged	1 Employees (FTE) 2026: 1 ▼ 1.4 vs 2025 (2.4) Unchanged	▼ 1.4

Key figures of Apotheek Vanderheyden Neeroeteren, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to Apotheek Vanderheyden Neeroeteren?

What happened at Apotheek Vanderheyden Neeroeteren in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 15, 2026 New annual accounts for financial year 2026: loss of € 181,264 (▼ € 282,881 vs 2025). Source: NBB ↗
2026 VANDERHEYDEN FARMA BV became a director. NBB
Apr 29, 1998 New establishment in Maaseik. KBO
Mar 20, 1998 Start of the company according to the CBE. KBO

In short

From € 109,432 profit in 2023 to € 181,264 loss in 2026.

Paid € 4,359 in corporate taxes since 2023.

Best year ever: 2023, with € 109,432 profit.

On average € 35,800 of value added per employee in 2026.

Original PDFs at the National Bank ↗

Management

SACRO 99.6%

The stake of SACRO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Vanderheyden Neeroeteren

Behind Apotheek Vanderheyden Neeroeteren is VANDERHEYDEN FARMA BV. The shares are held by SACRO (99.6%).

Directors

According to the 2026 annual accounts

VANDERHEYDEN FARMA BV

Director · represented by Geert Vanderheyden

Also active at: APOTHEEK GEERT VANDERHEYDEN

since 2026

Shareholders

SACRO

99.6%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Spilstraat 42

3680 Maaseik

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0462.921.909

VAT number

BE 0462.921.909

Registered office

Spilstraat 42, 3680 Maaseik

Names & denominations

Apotheek Vanderheyden Neeroeteren

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

20 March 1998

Peppol

Active · Active since 28 Apr 2026

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Vanderheyden Neeroeteren

Warning lights

Financials

What happened to Apotheek Vanderheyden Neeroeteren?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions